During the past decade, Rosemere Cancer Centre at Royal Preston Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rosemere Cancer Centre at Royal Preston Hospital" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "University College, London" with 3 trials sponsored, "Cancer Research UK" with 1 trials sponsored and "Cardiff University" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rosemere Cancer Centre at Royal Preston Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "Velindre NHS Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rosemere Cancer Centre at Royal Preston Hospital" are "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Extragonadal Germ Cell Tumor" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Rosemere Cancer Centre at Royal Preston Hospital" in a lesser frequency.

Most popular intervention types in "Rosemere Cancer Centre at Royal Preston Hospital" are "Drug" (14 trials), "Biological" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "carboplatin" (3 trials), "neoadjuvant therapy" (3 trials), "Cyclophosphamide" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rosemere Cancer Centre at Royal Preston Hospital" are 12 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Rosemere Cancer Centre at Royal Preston Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Rosemere Cancer Centre at Royal Preston Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rosemere Cancer Centre at Royal Preston Hospital, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".